Kymera Therapeutics Inc. (KYMR)
NASDAQ · Healthcare
Kymera Therapeutics Inc. Shareholder Equity 2019–2025
Kymera Therapeutics Inc. annual/quarterly shareholder equity history from 2019 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Kymera Therapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were 1.58B, a 89.04% increase year-over-year.
- Kymera Therapeutics Inc. shareholder equity for 2025 were 1.58B, a 89.04% increase from 2024.
- Kymera Therapeutics Inc. shareholder equity for 2024 were 835.6M, a 111.56% increase from 2023.
- Kymera Therapeutics Inc. shareholder equity for 2023 were 395.0M, a 19.42% decrease from 2022.
- Kymera Therapeutics Inc. shareholder equity for 2022 were 490.2M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Kymera Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $1,580 |
| 2024 | $836 |
| 2023 | $395 |
| 2022 | $490 |
| 2021 | $460 |
| 2020 | $284 |
| 2019 | $-74 |
| Kymera Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $1,580 |
| 2024-12-31 | $836 |
| 2023-12-31 | $395 |
| 2022-12-31 | $490 |
| 2021-12-31 | $460 |
| 2020-12-31 | $284 |
| 2019-12-31 | $-74 |
Kymera Therapeutics Inc. Shareholder Equity — FAQ
Kymera Therapeutics Inc. (KYMR) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KYMR's shareholder equity history?
The chart and table above show Kymera Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.